Additionally, genes that have clinical presentation and management that are not primarily endocrine tumor syndrome focused (e.g., PTEN with risks for thyroid cancer as well as risks for neurodevelopmental disorders, colorectal, breast, and endometrial cancers) were also excluded. This evidence concerns the gene PTEN and thyroid gland carcinoma.